OR10G7

Across TCGA pan-cancer cohorts, OR10G7 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated OR10G7 data layer compared with 5 for mutation status.

The strongest signal is observed in thyroid carcinoma (THCA), where higher OR10G7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR10G7 expression acts as an unfavorable survival marker.

THCA, ACC, and SKCM are the cancer types where OR10G7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.906	0.987	<.001	66	view →
ACC	DFS	Tertile	All	0.240	0.783	<.001	63	view →
SKCM	DFS	Tertile	All	0.058	0.757	<.001	36	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
PAAD	DFS	Tertile	III,IV	0.275	0.794	.008	33	view →
KIRP	OS	Tertile	II,III,IV	0.216	0.771	.049	9	view →
PCPG	DFS	Tertile	All	0.070	0.936	<.001	9	view →
SARC	OS	Tertile	All	0.492	0.770	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

OR10G7–THCA (OS)

Open the THCA breakdown →